Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

End-to-End Compression Anastomosis for Left-sided Colectomy Endo-CAR Study

This study has been completed.
Sponsor:
Information provided by:
Niti Medical Technologies Ltd.
ClinicalTrials.gov Identifier:
NCT00497263
First received: July 4, 2007
Last updated: June 28, 2011
Last verified: June 2011
  Purpose

the purpose of this study is to evaluate the safety and effectiveness of the Niti CAR-device in the creation of colorectal anastomosis


Condition Intervention Phase
Colorectal Cancer
Diverticulitis
Device: Niti CAR
Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label

Resource links provided by NLM:


Further study details as provided by Niti Medical Technologies Ltd.:

Primary Outcome Measures:
  • functioning anastomosis & no occurrence of adverse events related to device use [ Time Frame: during hospitalization and until 3 months after discharge ]

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Patient age over 18
  • Patient schedule for colonic surgery requiring E-t-E anastomosis
  • Patient is able to understand and to sign the Informed Consent Form

Exclusion Criteria:

  • Patient has known allergy to Nickel
  • Patient with bowel obstruction, strangulation, peritonitis, perforation, local or systemic infection
  • Patient on regular steroid medication
  • Patient with preexisting sphincter problems or evidence of extensive local disease of the pelvis
  • Patient following radiation (that compromised the anastomosis)
  • Patient who are undergoing a defunctioning stoma
  • Patient with contraindication to general anesthesia
  • Patient who is currently participating in other clinical trial
  • Patient who refuse consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00497263

Locations
Belgium
University Hospitals Gasthuisberg Leuven
Leuven, Brabant, Belgium, 3000
Sponsors and Collaborators
Niti Medical Technologies Ltd.
Investigators
Principal Investigator: André D'Hoore, MD, PhD University Hospitals Gasthuisberg Leuven
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00497263     History of Changes
Other Study ID Numbers: CLP-43-01 Rev 01
Study First Received: July 4, 2007
Last Updated: June 28, 2011
Health Authority: Belgium: Ministry of Social Affairs, Public Health and the Environment

Additional relevant MeSH terms:
Colorectal Neoplasms
Diverticulitis
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastroenteritis
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Infection
Intestinal Diseases
Intestinal Neoplasms
Intraabdominal Infections
Neoplasms
Neoplasms by Site
Rectal Diseases

ClinicalTrials.gov processed this record on November 20, 2014